This is unpublished

Emily
Liang
MD

Emily Liang

(206) 667-1345

1100 Fairview Ave. N, Seattle, WA 98109

General contact info

Physician & Research Faculty
Pinned
Academic
Assistant Professor, Clinical Research Division, Fred Hutch Cancer Center
Assistant Professor, Division of Hematology and Oncology, University of Washington
Sites of Practice
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center at UW Medical Center – Montlake

 

Education, Training, Board Certifications

  • MD, David Geffen School of Medicine at UCLA
  • Residency in Internal Medicine, Stanford University
  • Fellowship in Hematology and Oncology, Fred Hutch/University of Washington School of Medicine
  • Internal Medicine, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine
  • Hematology, American Board of Internal Medicine

Clinical Expertise

Blood and marrow transplantation, Immunotherapy

Affiliations

Fred Hutchinson Cancer Center

University of Washington

Publications

MyNCBI

Research and/or Clinical Interests

Dr. Emily Liang is a hematologist‑oncologist who cares for people with blood cancers and patients receiving innovative immune‑based treatments such as chimeric antigen receptor (CAR) T‑cell therapy, a type of treatment that uses a person’s own immune cells to fight cancer.

Dr. Liang’s research is centered on improving the safety of CAR T‑cell therapy. She conducts studies aimed at preventing and reducing treatment‑related side effects and  works to better understand why some patients experience more severe reactions than others, with the goal of making these therapies more predictable and accessible. Through both her research and her clinical practice, Dr. Liang is committed to advancing treatments that offer patients more effective options and a better quality of life.